|Hong-Bing Shu, Ph. D.|
National Jewish Medical Center
|Signaling by Tumor Necrosis Factor Family Members
2000 New Scholar Award in Aging
The majority of patients with cancer in the United States are more than 70 years old and cancer has been regarded as a disease of aging. Aging-related decline of the immune response has also been well documented. Our long-term goals are to identify molecular targets for drug development against cancer and immunological diseases.